CDK12 inhibitors (Carrick Therapeutics)

N/A

Report date: 2025/03/18 18:11:55
NME

Base Information

Drug NameCDK12 inhibitors (Carrick Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 12 inhibitors
TargetsCyclin-dependent kinase 12
Therapy Area/IndicationsTriple Negative Breast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarrick Therapeutics Uk Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCarrick Therapeutics Uk Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A